Nov. 22 at 4:13 AM
Based on my sister’s friend, repeating her
$TNGX employee son’s comment, there is considerable excitement within the company over a drug in Phase I/II testing for liver cancer (metastasized from ovarian cancer). My sister hopes to join the experimental protocol. I bought a small amount of the stock recently on that basis- so far it has worked well for me. YMMV- and be prepared for a bumpy ride, @LabPsycho.
